Oramed Pharmaceuticals Inc. (NASDAQ: ORMP)
$2.3550
+0.0450 ( +1.95% ) 74.5K
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
Market Data
Open
$2.3550
Previous close
$2.3100
Volume
74.5K
Market cap
N/A
Day range
$2.2200 - $2.3850
52 week range
$2.0000 - $3.6700
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 51 | May 09, 2024 |
8-k | 8K-related | 13 | May 06, 2024 |
4 | Insider transactions | 1 | Apr 18, 2024 |
3 | Insider transactions | 1 | Apr 02, 2024 |
8-k | 8K-related | 13 | Mar 19, 2024 |
8-k | 8K-related | 13 | Mar 18, 2024 |
8-k | 8K-related | 17 | Mar 18, 2024 |
10-k | Annual reports | 103 | Mar 06, 2024 |
8-k | 8K-related | 15 | Feb 20, 2024 |
4 | Insider transactions | 1 | Jan 30, 2024 |